Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB, American Association for Study of Liver Diseases: An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011, 54: 1433-1444. 10.1002/hep.24641.
Article
PubMed
PubMed Central
Google Scholar
Hoofnagle JH, Seeff LB: Peginterferon and ribavirin for chronic hepatitis C. N Engl J Med. 2006, 355: 2444-2451. 10.1056/NEJMct061675.
Article
PubMed
CAS
Google Scholar
Fellay J, Thompson AJ, Ge D, Gumbs CE, Urban TJ, Shianna KV, Little LD, Qiu P, Bertelsen AH, Watson M, Warner A, Muir AJ, Brass C, Albrecht J, Sulkowski M, McHutchison JG, Goldstein DB: ITPA gene variants protect against anemia in patients treated for chronic hepatitis C. Nature. 2010, 464: 405-408. 10.1038/nature08825.
Article
PubMed
CAS
Google Scholar
Thompson AJ, Fellay J, Patel K, Tillmann HL, Naggie S, Ge D, Urban TJ, Shianna KV, Muir AJ, Fried MW, Afdhal NH, Goldstein DB, McHutchison JG: Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction. Gastroenterology. 2010, 139: 1181-1189. 10.1053/j.gastro.2010.06.016.
Article
PubMed
CAS
PubMed Central
Google Scholar
Tanaka Y, Kurosaki M, Nishida N, Sugiyama M, Matsuura K, Sakamoto N, Enomoto N, Yatsuhashi H, Nishiguchi S, Hino K, Hige S, Itoh Y, Tanaka E, Mochida S, Honda M, Hiasa Y, Koike A, Sugauchi F, Kaneko S, Izumi N, Tokunaga K, Mizokami M: Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C. Hum Mol Genet. 2011, 20: 3507-3516. 10.1093/hmg/ddr249.
Article
PubMed
CAS
Google Scholar
Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, Ito Y, Mita E, Tanaka E, Mochida S, Murawaki Y, Honda M, Sakai A, Hiasa Y, Nishiguchi S, Koike A, Sakaida I, Imamura M, Ito K, Yano K, Masaki N, Sugauchi F, Izumi N, Tokunaga K, Mizokami M: Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 2009, 41: 1105-1109. 10.1038/ng.449.
Article
PubMed
CAS
Google Scholar
Hézode C, Forestier N, Dusheiko G, Ferenci P, Pol S, Goeser T, Bronowicki JP, Bourlière M, Gharakhanian S, Bengtsson L, McNair L, George S, Kieffer T, Kwong A, Kauffman RS, Alam J, Pawlotsky JM, Zeuzem S: Telaprevir and peginterferon with or without ribavirin for chronic HCV infection. N Engl J Med. 2009, 360: 1839-1850. 10.1056/NEJMoa0807650.
Article
PubMed
Google Scholar
Hoofnagle JH: Thrombocytopenia during interferon alpha therapy. JAMA. 1991, 266: 849-
Article
PubMed
CAS
Google Scholar
Yamane A, Nakamura T, Suzuki H, Ito M, Ohnishi Y, Ikeda Y, Miyakawa : Interferon-alpha 2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes. Blood. 2008, 112: 542-550. 10.1182/blood-2007-12-125906.
Article
PubMed
CAS
Google Scholar
Li L, Han DK, Lu J: Interferon-α induced severe thrombocytopenia: a case report and review of the literature. World J Gastroenterol. 2010, 16: 1414-1417. 10.3748/wjg.v16.i11.1414.
Article
PubMed
CAS
PubMed Central
Google Scholar
Emilia G, Longo G, Luppi M, Gandini G, Morselli M, Ferrara L, Amarri S, Cagossi K, Torelli G: Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood. 2001, 97: 812-814. 10.1182/blood.V97.3.812.
Article
PubMed
CAS
Google Scholar
Dumoulin FL, Leifeld L, Sauerbruch T, Spengler U: Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis. Biomed Pharmacother. 1999, 53: 242-254. 10.1016/S0753-3322(99)80095-X.
Article
PubMed
CAS
Google Scholar
Kamal SM, Fehr J, Roesler B, Peters T, Rasenack JW: Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. Gastroenterology. 2002, 123: 1070-1083. 10.1053/gast.2002.36045.
Article
PubMed
CAS
Google Scholar
Sagir A, Wettstein M, Heintges T, Haussinger D: Autoimmune thrombocytopenia induced by PEG-IFN-alpha2b plus ribavirin in hepatitis C. Dig Dis Sci. 2002, 47: 562-563. 10.1023/A:1017964002402.
Article
PubMed
Google Scholar
Johnsen J: Pathogenesis in immune thrombocytopenia: new insights. Hematology Am Soc Hematol Educ Program. 2012, 2012: 306-312.
PubMed
Google Scholar
George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, Vondracek T: Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med. 1998, 129: 886-890. 10.7326/0003-4819-129-11_Part_1-199812010-00009.
Article
PubMed
CAS
Google Scholar
Aster RH, Bougie DW: Drug-induced immune thrombocytopenia. N Engl J Med. 2007, 357: 580-587. 10.1056/NEJMra066469.
Article
PubMed
Google Scholar